FDA Says Shortage Is Over, Compounders Have 60-90 Days
Dec. 20, 2024 The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, eliminating the need for copycat versions of the drugs that have become wildly popular with Americans trying to lose weight. Zepbound is FDA-approved to treat obesity and Mounjaro is approved for diabetes. They […]
FDA Says Shortage Is Over, Compounders Have 60-90 Days Read More »